But queries remain concerning whether bilateral cochlear implants.

Henkin. Presently it is not feasible to coordinate the procedure of individual bilateral implants, however in the near future these implants could be designed to synchronize with one another, providing the hearing-impaired individual with the cues necessary for binaural processing, she says. Further to authorization by america FDA , BioAlliance Pharma shall prolong its scientific trial to america, increasing the amount of clinical investigation centers involved with this randomized dual blind stage II trial. Related StoriesNew antenna-like gadget makes breast cancer medical procedures less difficult for surgeonsFDA grants accelerated acceptance for Tagrisso to take care of individuals with advanced NSCLCNew results reveal association between colorectal cancers and melanoma medications So far nearly 50 percent of planned individuals have been signed up for about 30 European centers.‘Uncertainty can be unsettling, nonetheless it is a small price to pay for protecting ourselves and our kids from thousands of preventable cancers,’ they conclude.. Champions Oncology operating revenues increase to $7.1M for the 12 months ended April 30, 2012 Champions Oncology, Inc. , formerly Champions Biotechnology, Inc., partcipates in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today its financial outcomes for the year ended April 30 announced, 2012.